Back to search

Article

Downregulation of Gankyrin/PSMD10 affects cancer cell growth and proliferation in glioblastoma: <i>in vitro</i> and <i>in vivo</i> study

2024-12-05

Abstract excerpt

The oncoprotein Gankyrin/PSMD10 is upregulated in various cancers, including glioblastoma multiforme (GBM), the most difficult tumor to treat. The heterogeneity of this type of tumor requires a multi-targeted approach to overcome radio- and chemoresistance. Here we aim to investigate the effects of Gankyrin inhibition on glioma cell proliferation and its impact on sensitivity to chemotherapy both in vitro and in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
058a2d6f-ebd7-5b09-b4e7-cbe6645fae9c
DOI
10.1101/2024.12.02.626412
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Downregulation of Gankyrin/PSMD10 affects cancer cell growth and proliferation in glioblastoma: <i>in vitro</i> and <i>in vivo</i> studyDOI 10.1101/2024.12.02.626412
Select a neighboring publication to make it the new centre.